David Shank Fry,Christopher M. Lindemann,Michael Preigh,Corey Jay Bloom,Christopher Donovan Craig,Devon Brevard Dubose,Jeff Gautschi,Dan Smithey
申请号：
US16353951
公开号：
US20190275043A1
申请日:
2019.03.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.
